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Abstract
Summary
The pathogenesis forof low trauma wrist fractures in men is not fully
understood. This study found that these men have lower bone mineral density
at the forearm itself, as well as the hip and spine, and has shown that forearm
bone mineral density is the best predictor of wrist fracture.
Introduction
Men with distal forearm fractures have reduced bone density at the lumbar
spine and hip sites, an increased risk of osteoporosis and a higher incidence
of further fractures. The aim of this case-control study was to investigate
whether or not there is a regional loss of bone mineral density (BMD) at the
forearm between men with and without distal forearm fractures.
Methods
Sixty-one men with low trauma distal forearm fracture and 59 age-matched
bone healthy control subjects were recruited. All subjects underwent a DXA
scan of forearm, hip and spine, biochemical investigations, health
questionnaires, SF-36v2 and Fracture Risk Assessment Tool (FRAX). The
non-fractured arm was investigated in subjects with fracture and both
forearms in control subjects.
Results
BMD was significantly lower at the ultradistal forearm in men with fracture
compared to control subjects, in both the dominant (mean (SD) 0.386 g/cm
(0.049) versus 0.436 g/cm  (0.054), p < 0.001) and non-dominant arm (mean
(SD) 0.387 g/cm  (0.060) versus 0.432 g/cm  (0.061), p = 0.001). Fracture
subjects also had a significantly lower BMD at hip and spine sites compared
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with control subjects. Logistic regression analysis showed that the best
predictor of forearm fracture was ultradistal forearm BMD (OR = 0.871
(0.805–0.943), p = 0.001), with the likelihood of fracture decreasing by
12.9% for every 0.01 g/cm  increase in ultradistal forearm BMD.
Conclusions
Men with low trauma distal forearm fracture have significantly lower
regional BMD at the ultradistal forearm, which contributes to an increased
forearm fracture risk. They also have generalised reduction in BMD, so that
low trauma forearm fractures in men should be considered as indicator
fractures for osteoporosis.
Keywords
Bone density
DXA
Forearm fracture
Male
Osteoporosis
Electronic supplementary material
The online version of this article (doi: 10.1007/s00198-017-4122-0 ) contains
supplementary material, which is available to authorized users.
Introduction
Male osteoporosis is a common condition resulting in compromised bone
strength and increased risk of fractures with age. For men over the age of
50 years, there is a 1 in 5 lifetime risk of fracture and men account for 20–30%
of all fractures [1]. Life expectancy is increasing at a higher rate for men than
for women and based on these demographics an 89% increase in hip fractures
has been predicted by 2025 [2]. The standardised mortality ratio for all fractures
compared with age-matched healthy subjects is higher in men than women [3, 4,
5]. Despite this, there has been less research into male osteoporosis compared
with women and male osteoporosis continues to be both under-diagnosed and
under-treated.
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Factors involved in the pathogenesis of distal forearm fractures in Caucasian
men are of interest because they are considered an “early and sensitive marker
of skeletal fragility” [6]. Men who have had a distal forearm fracture have a 2.7-
fold and 10.7-fold increased risk for hip and vertebral fractures respectively
compared with age-matched men who have not fractured [7]. In retrospective
studies, low areal bone mineral density (BMD) was identified at the hip and
spine with up to 42% of men with this type of fracture having osteoporosis [8,
9]. One of those studies found that approximately 50% of men with fractures
had secondary causes for osteoporosis such as glucocorticoid use [8]. It is
possible that varying rates of bone loss at different skeletal sites may predispose
to particular fracture types. It is not known if men with distal forearm fractures
have reduced BMD at the distal forearm. It has been demonstrated that about
60% of distal forearm fractures occur on the left [8, 10, 11], and it is speculated
that this may be due to reduced BMD in the non-dominant arm. FRAX is a well-
validated tool for identifying individuals at risk of hip and other major fractures
[12, 13]. FRAX has not been tested for its ability to identify men at risk of
forearm fractures.
There have been no studies of forearm BMD, health parameters and FRAX in
men with distal forearm fractures. To address this deficiency, we have
undertaken a case-control study to further investigate these fractures in men.
The aim was to test the hypothesis that men with low trauma distal fractures
have lower regional BMD at the forearm compared to control subjects without
fracture.
Materials and methods
Study design and participants
This investigation is an age-matched case-control study: the pathogenesis of
Male distal foRearm Fracture study or the Mr F study. Subjects were recruited
from one geographical area (catchment area of The James Cook University
Hospital, Middlesbrough, UK, and its environs) over a period of 28 months.
All subjects were Caucasian males 50 years and older as the majority of
fractures in men under 50 years of age are due to high trauma or assault [8].
Written informed consent was obtained from all participants.
Subjects with low trauma distal forearm fracture (defined as fractures of the
distal radius with or without fracture of the distal ulna) were identified within
6 months of their fracture from hospital databases. Age-matched control
subjects without fracture were identified from the patient register of
collaborating GP practices, which were from rural as well as urban areas to
ensure that recruited control subjects were representative of the overall
population in the catchment area of the hospital.
Subjects were excluded from participation if: they were unable to provide
informed consent, were already receiving treatment for osteoporosis (including
calcium and vitamin D) or received it after the fracture, had known metabolic
bone disease (e.g. Paget’s disease of bone, osteomalacia, osteopetrosis,
hyperparathyroidism, treated hypogonadism), malignancy or fractures due to
metastatic disease. Subjects with fracture were also excluded if the fracture was
not united at the time of the study visit, was the result of high-energy trauma,
road traffic accident or assault and if they had sustained bilateral forearm
fractures or other major fractures at the time of the distal forearm fracture.
Control subjects were also excluded if they had a history of low trauma fracture
at any location (excluding digits) or had sustained a fracture in the last
6 months.
Study questionnaires
All potential participants were approached by mail and asked to complete a
questionnaire, which could be returned even if they decided not to take part in
the main study, to allow insight into the differences between participants and
non-participants. The baseline questionnaire collected the following data: name,
date of birth, gender, weight and height (subsequently measured using a
standard scale and stadiometer when attending for dual-energy X-ray
absorptiometry (DXA)), hand dominance, site of fracture (where relevant),
mechanism of injury, history of previous fractures, risk factors for osteoporosis
including current smoking and alcohol intake, medical history and medication.
BMI was calculated as weight/height  in kg/m . Participants completed the
SF36v2 health survey to provide a profile of functional health and well-being
scores as well as a physical and mental health summary.
The 10-year percentage risk of fracture (major and hip) was calculated using the
Fracture Risk Assessment Tool (FRAX) both with and without inclusion of the
lowest femoral neck BMD [13]. For subjects with fracture, ‘pre-fracture’ and
‘post-fracture’ risks were calculated. The need for treatment was then
established for all participants using the National Osteoporosis Guideline Group
(NOGG) clinical guideline for the management of men and women at high
2 2
fracture risk in the UK [14]. Those individuals with a sufficiently high fracture
risk were seen in clinic and received treatment after completing the study
protocol.
Biochemical investigations
Participants had blood taken to detect abnormalities and look for secondary
causes of osteoporosis or fracture. Participants with fracture were investigated
at a minimum of 6 months following their fracture. Where possible, subjects
had their blood tests evenly distributed throughout the year; but due to the
seasonal variation in fracture incidence, this was not always achieved. All
bloods were taken between 8.15 and 9.45 am with the patient fasting. Two
participants did not attend for blood tests.
The laboratory investigations included full blood count, urea and electrolytes,
bone profile (including ionised and albumin adjusted calcium, albumin,
inorganic phosphate and alkaline phosphatase), liver function tests, ESR, CRP,
fasting blood sugar, TSH, PTH, total 25 hydroxyvitamin D (25OHD), total
oestradiol, bioavailable oestradiol, total testosterone and bioavailable
testosterone. Details of the assays and analysers used are given in Online
Resource 1. Vitamin D levels were defined as deficient <25 nmol/L, insufficient
25–50 nmol/L and sufficient as >50 nmol/L [15, 16].
Dual-energy X-ray absorptiometry
All participants underwent a DXA scan to determine BMD at the lumbar spine
(L2–L4), forearm (ultradistal and distal one third of the radius) and both hips
(femoral neck and total hip sites). Subjects with fracture had a scan of the non-
fractured forearm at 3 to 6 months after fracture whereas control subjects had
both forearms scanned at the time of recruitment. At the lumbar spine, lateral
views for vertebral morphometry were also undertaken to assess for vertebral
fractures, using the Genant and Wu semiquantitative approach to confirm [17,
18, 19]. All BMD measurements were performed on the same DXA scanner
throughout (Lunar Prodigy Advanced, GE Healthcare Lunar, Madison,
Wisconsin, USA, version 13.6). To reduce bias the same, independent
radiographer carried out all DXA measurements, and stability and accuracy
were monitored daily using a manufacturer-supplied phantom. The coefficient
of variation (CV), measured using a local spine phantom, was a mean of 1.24%
and all were less than 1.5%. All quality assurance checks were well within
manufacturer’s tolerances throughout the study. T-scores were derived using the
manufacturer’s reference ranges for males at the lumbar spine and forearm and
the NHANESIII reference database at the hip sites for males 20–39 years of
age. Z-scores were also determined. T-scores at the hip sites were further
developed using female reference databases from NHANESIII in light of the
recent recommendations to use femoral neck BMD to calculate fracture risk and
determine T-scores [20]. Osteoporosis was defined as per WHO definition [21]
as a T-score ≤ −2.5 SD below the mean for a young person with osteopenia
being between > −2.5 and < −1.0 SD and normal being ≥ −1.
Sample size calculation
As no data on BMD at the forearm was available for men, the sample size
calculation has been based on the difference in BMD at the femoral neck in men
with and without distal forearm fracture. Using data from Tuck et al. [8], 50
subjects were needed in each group to detect a mean difference of 0.103 g/cm
with a standard error of 0.01 and standard deviation of 0.1107 in the fracture
group and 0.1169 in the control group with a power of 90% at the 5%
significance level. To allow for attrition, 60 participants were to be recruited to
each group.
Statistical analysis
Statistical analysis was performed using a standard software package (SPSS for
Mac, V21). All significance tests were two-tailed and carried out at the 5%
level. Missing data were not replaced. Subject demographic details and outcome
measures were summarised by fracture and control group with quantitative
variables summarised by the mean, median, standard deviation, minimum and
maximum and categorical variables summarised by the number of subjects and
percentage in each category. All quantitative data were tested for normality and
log transformation performed if data were not normally distributed at initial
testing. Data were further analysed using paired- and independent t-test for
normally distributed data or Wilcoxon rank sum test for non-parametric data.
Pearson correlation coefficients were determined to investigate the relationship
between multiple factors and BMD. Values for dominant and non-dominant
forearm were calculated using data from the available forearm from the fracture
group with data from allboth forearms from control participants.
Multiple linear regression analysis using forward selection of variables was
performed to further examine the association between correlated factors and
BMD at all sites. For the analysis of BMD at the ultradistal and distal third
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forearm sites, fracture subjects had only one set of measurements available, i.e.
the non-fractured arm, whereas control subjects had measurements at both
forearms, i.e. right and left. To allow comparison between all participants, one
value had to be chosen for the control group and the lower value of either right
or left forearm was selected for each forearm site and compared with the
available measurement for the fracture group.
To identify factors that increased the likelihood of fracture in the study cohort,
clinically relevant factors and factors where there was a significant difference
between groups, based on t-tests for continuous normally distributed and Mann-
Whitney-U test for continuous not normally distributed variables, were chosen.
A logistic regression model was fitted with independent variables using a
forward selection method (based on the likelihood ratio test). Odd ratios (OR)
and confidence intervals were reported. Due to the low magnitude of the
numerical values for lowest ultradistal forearm BMD when entering them in
gramme per square centimetre, a new variable was created by multiplication
with 100 to present a percentage change per 0.01 g/cm .
Results
Responses
Figure 1 illustrates the numbers of subjects approached, excluded and agreeing
to take part. Ultimately, 61 fracture and 59 control subjects were recruited.
There was no statistically significant difference in age between subjects who
took part in the study and subjects who did not take part in either the fracture or
control group. Subjects who only answered the questionnaire were older than
subjects who took part in the study (mean age 68.7 and 65.3 respectively,
p = 0.015), but there were no statistically significant differences in height,
weight, health and lifestyle factors. Two participants in the fracture group did
not attend for blood tests and SF36v2 completion due to difficulties of attending
an early morning appointment.
Fig. 1
Flow chart participant recruitment
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Subject characteristics
There were no significant differences in mean age and anthropometric indices
between the fracture and control group as shown in Table 1. There was no
difference in the proportion of fracture cases and control subjects with excess
alcohol consumption (>21 units per week), current smoking, prior fragility
fractures, pre-existing co-morbidities which could impact on bone health or
medical conditions. There was a statistically significant difference in the
physical component score of the SF36v2 between fracture and control
participants (p = 0.045), but no difference in the mental component score
(p = 0.371) at a minimum of 6 months following the fracture. Although most of
the participants in the fracture group were right hand dominant (88.5%),
subjects were almost equally likely to fracture the non-dominant or dominant
arm with (52.5 vs. 47.5%, p = 0.789; Online Resource 2, Table 1).
Table 1
Subject characteristics
 Fracture(n = 61)
Control
(n = 59)
p-
value
Mean age (years) 64.0 (9.1) 66.6 (8.9) 0.119*
Height (cm) 1.73 (0.7) 1.73 (0.8) 0.908*
Weight (kg) 83.7 (14.5) 82.6 (12.1) 0.651*
BMI 28.0 (4.4) 27.6 (3.4) 0.541*
Health questionnaire
 Smoking (current) 5 (8.2%) 1 (1.7%) 0.207
 Alcohol > 21 units 14 (23%) 15 (25%) 0.752
 Previous fractures (adult, low
trauma) 7 (11.5%) 2 (3.4%) 0.090
 Bone diseases 0 0  
 Medications affecting bone 0 0  
 Glucocorticoids 1 (1.6%) 1 (1.7%) 0.744
 Medical conditions 34 (55.7%) 25 (42.4%) 0.143
 Diabetes 6 (9.8%) 2 (3.4%) 0.273
 Rheumatoid arthritis 0 0  
 Further secondary causes 1 (1.6%) 2 (3.4%) 0.487
 Parental hip fracture 6 (9.8%) 2 (3.4%) 0.147
SF 36 scores
 SF-36 PCS 51 (7) 54 (8) 0.045*
 SF-36 MCS 57 (7) 55 (7) 0.371
Mean (SD) or number and percentages for demographic characteristics; SF-36v2
median and IQR. Glucocorticoids,: >7.5 mg prednisolone equivalent. Medical
conditions: ischaemic heart disease, cardiac arrhythmia, hypertension, stroke,
treated reflux disease, gout. Further secondary causes: COPD, Asthma, cystic
fibrosis, Coeliac disease, thyrotoxicosis, ankylosing spondylitis.
AQ2
PCS physical component score, MCS mental component score
* t-test
Fisher’s exact
Pearson’s chi square
Mann-Whitney-U
+
&
+
+
&
+
+
+
$
+
&
$
The results of the FRAX estimates of 10-year fracture risk are given in Table 2.
There was no significant difference in FRAX estimates between the two groups
prior to the inclusion of lowest femoral neck BMD. This became significantly
different with higher risk estimates in the fracture group once BMD or fracture
or both were included in the calculation. Using FRAX calculated after inclusion
of fracture and femoral neck BMD 13, participants (21%) in the fracture group
compared to no participants in the control group were above NOGG treatment
thresholds and would require treatment based on their fracture risk.
Table 2
Mean and SD for 10-year fracture risk (%) with and without BMD at baseline prior to
fracture and after forearm fracture using FRAX
Prior to fracture
FRAX Fracture Control p-value
BL without BMD–MO 5.24 (2.47) 5.27 (2.06) 0.702*
BL without BMD–Hip 1.27 (1.51) 1.45 (1.44) 0.299*
BL with BMD–MO 6.28 (2.89) 5.16 (1.83) <0.001*
BL with BMD–Hip 1.63 (1.47) 1.17 (1.11) 0.001*
Including history of fracture
 SV without BMD–MO 9.32 (3.08) 5.27 (2.06) 0.033*
 SV without BMD–Hip 2.36 (2.03) 1.45 (1.44) 0.095*
 SV with BMD–MO 9.85 (3.88) 5.16 (1.83) <0.001*
 SV with BMD–Hip 2.47 (2.04) 1.17 (1.11) <0.001*
BL baseline, SV study visit, MO major osteoporotic fracture, Hip hip fracture
*t-test on log-transformed data
Blood results
The results of biochemical and haematological laboratory investigations are
shown in Table 2 of Online Resource 2. The only significant difference between
the two groups was that the mean serum 25OHD concentration was higher in the
fracture group compared with the control group (66.9 vs. 53.0 nmol/L,
p = 0.003). This difference lost significance once adjustment for season in
which the blood samples were taken had been made. There was no statistically
significant difference between the groups when comparing vitamin D status
(sufficient, insufficient, deficient) (X  = 3.512, N = 118, p = 0.173). Of note,
there was no significant difference between the groups in PTH, renal function,
alkaline phosphatase, adjusted calcium, oestradiol or testosterone.
Bone mineral density
There was significantly lower BMD at all sites in the fracture group compared
with the control group except at the non-dominant distal one third forearm and
the distal one third forearm (Table 3). Notably, there was significantly lower
BMD at the ultradistal forearm (both dominant and non-dominant arm) and
distal one third forearm (dominant arm only) in the fracture subjects compared
with control subjects. Interestingly, there was no difference in BMD between
the dominant and non-dominant forearm in the control subjects at the ultradistal
radius (p = 0.304) and the distal one third radius (p = 0.080). At those sites
where BMD was significantly lower, the percentage reduction in the fracture
group compared with controls varied between 5.1 and 11.5%, with greatest
reduction being seen at the ultradistal forearm sites. As a result of the lower
BMD, the T- and Z-scores of these men (using male normative data) were
significantly lower in the fracture subjects versus the control subjects as shown
in Table 3 of Online Resource 2.
Table 3
BMD results (in g/cm )
BMD Fracture(n = 61)
Control
(n = 59)
Percentage
reduction
p-
value
Lumbar spine L2–L4 1.193(0.176)
1.274
(0.207) 6.4 0.024
Right femoral neck 0.909(0.115)
0.969
(0.123) 6.2 0.007
Left femoral neck 0.892(0.131)
0.961
(0.138) 7.2 0.006
Right total hip 0.982(0.124)
1.055
(0.127) 6.9 0.002
Left total hip 0.972(0.130)
1.050
(0.149) 7.4 0.001
Dominant ultradistal
FA*
0.386
(0.049)
0.436
(0.054) 11.5 <0.001
2
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Non-dominant
ultradistal FA*
0.387
(0.060)
0.432
(0.061)
10.4 0.001
Dominant distal one
third FA*
0.741
(0.066)
0.781
(0.065) 5.1 0.007
Non-dominant distal
one third FA*
0.750
(0.064)
0.772
(0.061) 2.8 0.127
Ultradistal FA 0.387(0.054)
0.423
(0.057) 8.5 0.001
Distal one third FA 0.745(0.065)
0.760
(0.063) 2.0 0.178
Values for dominant and non-dominant forearm were calculated using data from
the available forearm from the fracture group with data from allboth forearms
from control participants
FA forearm
*For the analysis of dominant forearm measurements, 29 fracture subjects were
compared with 59 control subjects. For the analysis of non-dominant forearm
measurements, 32 fracture subjects were compared with 59 control subjects
Using male normative data, 11.5% per cent were found to be osteoporotic at the
lumbar spine or hip sites in the fracture group and 5.1% in the control group
(Fisher’s exact, p = 0.324). This rises to 13.1 and 5.1% respectively if forearm
sites are included (X  = 2.236, N = 119, p = 0.206). At the femoral neck alone,
these figures are 11.5 and 3.4% (Fisher’s exact, p = 0.164). These differences
were not statistically significant.
Using female reference data at the femoral neck to define osteoporosis [20]
reduces the proportion of osteoporotic participants to just 3.3% in the fracture
group and zero in the control group.
BMD at multiple sites was found to associate with age, height and weight;
adjusted calcium with the dominant ultradistal and both dominant and non-
dominant distal one third forearm; bioavailable oestradiol with the non-
dominant ultradistal forearm; total oestradiol with the distal one third forearm
and finally TSH with the hip sites (Online Resource 2, Table 4). The observed
differences in BMD between the two groups persisted at all sites after making
adjustments for these factors.
Table 4
Logistic regression analysis for fracture prediction
2
Step Variable B
AQ3
SE Significance
AQ4
Odds ratio (95%
CI)
Step
1
UDFA
BMD100 −0.138 0.040 0.001 0.871 (0.805–0.943)
Constant 5.498 1.635 0.001 NA
The following variables were entered into the analysis: vitamin D adjusted,
lumbar spine BMD, right femoral neck BMD, left femoral neck BMD, right total
hip BMD, left total hip BMD, ultradistal and distal one third forearm BMD
B = unstandardised coefficients, SE = standard error ​, ​ UDFA BMD100 = UDFA
BMD × 100, UDFA BMD = ultradistal forearm BMD
Predictors of likelihood of fracture This is a subheader and should be in the same
size/style as the following subheader "Predictors of BMD"
The following clinically relevant variables that were found to be statistically
significantly different between the fracture and control group (Table 1, Online
Resource 2 Table 2) were entered into a logistic regression analysis: vitamin D,
lumbar spine BMD, right femoral neck BMD, left femoral neck BMD, right
total hip BMD, left total hip BMD, ultradistal and distal one third forearm
BMD. Vitamin D was adjusted for seasons and adjusted values entered into the
regression model. Only ultradistal forearm BMD remained as a significant
variable in the final model. The regression analysis (Table 4) shows that the
likelihood of fracture was decreased by 12.9% for every 0.01 g/cm  increase in
ultradistal BMD.
Predictors of BMD
In order to determine the best predictors of BMD in all subjects, linear
regression models were fitted with independent variables selected by forward
selection for each individual site. Age, height and weight were seen as
potentially predictive at all sites and were entered in all models. Further,
significantly correlated factors relevant to each site (Online Resource 2, Table
4) were added into the model relevant for the individual sites (Table 5).
Table 5
Linear regression models to predict BMD for all subjects at individual sites
Variable
Model 1 Model 2 Model 3
B SE B β BAQ5 SE B β B SE B
2
Lumbar spine L2–L4 BMD
 E2 0.001 0.001 0.190 0.001 0.001 0.204*   
 
Height    0.520 0.248 0.289*   
 
Adjusted
R2
0.028 0.055  
 F
change 4.296* 4.375*  
Right femoral neck BMD
 
Weight 0.002 0.001 0.268** 0.002 0.001 0.238*   
 TSH    0.021 0.010 0.185*   
 
Adjusted
R2
0.063 0.089   
 F
change 8.636** 4.120*   
Left femoral neck BMD
 Age −0.005 0.001 −0.321** −0.004 0.001 −0.274**   
 
Height    0.445 0.172 0.228*   
 
Adjusted
R2
0.095 0.138   
 F
change 13.085** 6.662*   
Right total hip BMD
 
Weight 0.003 0.001 0.258**      
 
Adjusted
R2
0.058      
 F
change 8.008**      
Left total hip BMD
 
Weight 0.003 0.001 0.246**      
The best fitting model at the lumbar spine BMD accounted for 5.5% of the
variation and incorporated height and total oestradiol. For the right femoral
neck the model included weight and TSH and explained 8.9% of the variation,
whereas at the left femoral neck 13.8% was accounted for by a model
incorporating age and height. At both total hip sites, only weight was predictive
 
Adjusted
R2
0.052      
 F
change 7.342**      
Ultradistal forearm BMD
 BioE2 0.002 0.001 0.236* 0.002 0.001 0.250**   
 
Adjusted
Ca
   −0.142 0.065 −0.196*   
 
Adjusted
R2
0.048 0.078   
 F
change 6.800* 4.792*   
Distal one third forearm BMD
 
Height 0.354 0.076 0.397** 0.367 0.074 0.412** 0.330 0.074
 
Adjusted
Ca
   −0.205 0.065 −0.260** −0.185 0.065
 Age       −0.001 0.001
 
Adjusted
R2
0.151 0.212 0.237
 F
change 21.568** 9.936** 4.830*
eight The variables age, height and weight were entered for each site. The following variables
were additionally entered into the analysis at individual sites: lumbar spine BMD: creatinine,
total oestradiol (E2); right and left femoral neck BMD, right and left total hip BMD: TSH;
ultradistal forearm BMD: adjusted calcium, bioavailable oestradiol (BioE2); distal one third
forearm BMD: adjusted calcium, total oestradiol (E2)
B = unstandardised coefficients, SE = standard error, ß = standardised coefficients *
**p < 0.01
producing a model that explained 5.8% of the right and 5.2% of the left BMD.
At the ultradistal forearm the best model used bioavailable oestradiol and
adjusted calcium to predict 7.8% of BMD, and at the distal one third this was
height, age and adjusted calcium to account for 23.7% of the variance.
Discussion
This is the first study to examine forearm BMD in men with distal forearm
fracture, finding significantly lower BMD in fracture subjects at the ultradistal
and distal one third of the non-fractured forearm compared with the forearm
BMD in control subjects. Regression analysis also showed that the likelihood of
fracture decreases as BMD at the ultradistal radius site increases. These findings
are consistent with the study hypothesis and emphasise the importance of
regional BMD in the pathogenesis ifof these fractures. Similar findings were
reported in a study by Farr et al. [22], which showed that already in childhood
and adolescence boys with low trauma distal forearm fracture had skeletal
deficits compared to control subjects.
As in previous studies, BMD was also significantly lower at other sites, such as
the hip and spine or heel compared with age- and gender-matched control
subjects [8, 9, 23, 24]. The significantly lower areal BMD persisted after
adjustment for confounders. This suggests a higher future fracture risk at all
sites, which Cuddihy et al. [7] confirmed with a 2.7-fold and 10.7-fold
increased risk for hip and vertebral fractures respectively after a distal forearm
fracture compared with age-matched men. Lower femoral neck BMD has also
been identified as a risk factor for wrist fractures in an epidemiological study by
Nguyen et al. [25].
The greatest percentage reduction in BMD compared with controls was at the
ultradistal site, which has previously only been observed in women with
forearm fractures [26]. In men with vertebral fractures and hip fractures, the
greatest percentage reduction in BMD was observed at the lumbar spine and hip
sites respectively [27, 28] and lumbar spine and hip BMD were the best
predictors for fractures at these sites [28, 29]. This suggests that an element of
regional bone loss may be contributing to the site of fracture occurrence.
Furthermore, in control subjects there was no difference in BMD between the
dominant and non-dominant forearm. This might explain why the men were
equally likely to fracture the dominant or non-dominant forearm. By contrast, in
women, lower BMD has been reported in the non-dominant forearm [30, 31, 32]
and this difference has been hypothesised to explain why women are more
likely to fracture the non-dominant arm.
Using male normative data, the proportion of men with osteoporosis in at least
one site (lumbar spine, femoral neck or total hip) was 11.5%, which rises to
13.1% if the forearms are included. This is much lower than the 42% seen
previously by Tuck et al. [8] and the 23.3% found by Egund et al. in men over
65 years [9]. In the current study, participants had very few medical problems or
secondary causes (Table 1) and there were no differences between the groups. In
contrast, Tuck et al. [8] and Egund et al. [9] found that up to 51% of subjects
with forearm fractures and up to 37% of control subjects had secondary causes.
Tuck et al. further reported a higher incidence of previous adult low trauma
fracture with 47% in the fracture and 45% in the control group compared to
11.5% and 3.4% in our study cohort [8].
Overall predictors of BMD varied with different sites and included age, height,
weight, adjusted calcium, TSH and oestradiol. This is consistent with previously
published studies [8, 27, 28]. The association between BMD and TSH has had
conflicting results [33, 34], although Grimes et al. [33] found that men with
very low TSH had low forearm BMD and argued that TSH may have bone
protective properties. In the present study, the strongest predictors of forearm
BMD were bioavailable oestradiol and adjusted calcium for the ultradistal
forearm and age, height and adjusted calcium for the distal one third forearm.
There was no association with TSH.
Interestingly, in our study population there was no difference in 10-year
predicted fracture risk as calculated by FRAX until BMD and/or the fracture
were included. It would therefore have not been possible to identify these male
subjects as at risk during routine screening prior to knowing BMD. FRAX is
well validated for predicting major and hip fractures in both genders [35, 36, 37,
38, 39], but major fractures are all grouped together [12, 13] as there were too
few fractures of any one type to develop an algorithm for them individually. The
European Osteoporosis Study looked at Colle’s fractures separately, but was
unable to find any predictors for forearm fractures in men [39].
The strengths of the study are that the cohorts are very clearly defined by
stringent inclusion criteria and there are very few confounders that could affect
the outcomes. Subjects in fracture and control group were well and there are
very few differences between the groups identified by questionnaire or blood
tests. Study investigations have been carried out by the same individuals
throughout the study, ensuring consistent data collection with accurate timing of
follow-up assessments and taking of blood samples.
A limitation of this study is its small sample size with only 59 fracture subjects.
A larger study may identify further important factors in the pathogenesis of
these fractures in men. However, the study was adequately powered to detect
the observed differences in BMD and included more participants than other
published comparative studies [23, 24]. It is also a case-control design, which
introduces potential recall bias from participants. Only 58% of eligible
participants in the fracture and 61% in the control group agreed to take part in
the study, resulting in possible selection bias. However, comparing data from
participating subjects and subjects who only provided questionnaire data
revealed no significant differences.
Prior fragility fracture was an exclusion criterion for control but not fracture
subjects, which could have potentially accentuated differences between the two
groups. However, there were only seven prior fragility fractures identified in the
fracture group and two in the controls, a difference that was not statistically
significant. Furthermore, the FRAX risk estimates were not significantly
different between the two groups until BMD and/or forearm fracture were
added. It therefore seems unlikely that such a bias occurred.
Participants in the fracture group may have altered their activity levels and use
of the injured hand, which could have affected regional BMD. The lower score
in the physical domain of SF36v2, even though not clinically significant, could
be an indicator of this. However, the non-fractured forearm was scanned, which
may on the contrary have been used more to compensate for the loss of function
in the fractured arm. In addition, there was no difference between groups in the
activity level captured during their falls risk assessment. BMD changes also
occur slowly, so that BMD measurement 3 to 6 months after fracture are
unlikely to detect a significant reduction in BMD given the relatively minor
nature of the fracture.
In conclusion, FRAX calculated prior to fracture could not identify these men at
higher fracture risk until femoral neck BMD was added. Further risk factors
may need to be found if these men are to be identified prior to fracture. This
study is also the first to demonstrate significantly lower BMD at the forearm in
fracture subjects compared with controls. The greatest percentage reduction in
BMD compared with control subjects was at the ultradistal forearm and the best
predictor of forearm fracture was ultradistal forearm BMD. We suggest that all
men with low trauma distal forearm fractures should be considered at risk of
osteoporosis and further fractures. Further work is required to understand their
pathogenesis.
Acknowledgements
The authors would like to thank all patients and volunteers who took part in the
study. ​They are grateful to ​ Dr. Peter James, Institute of Health and Society, Sir
James Spence Institute, Royal Victoria Infirmary, UK, for his assistance with
the statistical analysis required in the preparation of the manuscript, Mrs. Gill
Wheater for undertaking the laboratory tests and Mrs. Jackie Bates for
performing the DXA scans.Jun Jie Wu further acknowledges with gratitud ​e the
support given by the Engineering Physical Science Research Council grant
(EP/K036939/1) for which she was the Durham principal investigator.
Compliance with ethical standards
Funding This study was funded by a grant from the National Osteoporosis
Society (Grant number: 75/190).
Conflict of interest Birgit Hanusch, Stephen Tuck, Harish Datta and Roger
Francis have received grants from the National Osteoporosis Society. Birgit
Hanusch, Stephen Tuck, Jun Jie Wu, Birgit Hanusch and Julie Walker are also
supported by an innovative award from the National Osteoporosis Society
(Grant number CS/250). Roger Francis has served as an adviser to Consilient,
Internis, Amgen and MDS and has received speaker fees from Consilient,
Servier, Amgen, Takeda and ProStrakan. Stephen Tuck has received speaker
fees from Ely Lilly, Servier, Internist and Amgen. Jun Jie Wu is receiving
financial support from an Engineering Physical Science Research Council grant
EPSRC (EP/K036939/1). Richard McNally, Michael Prediger, Jonathan Tang,
Isabelle Piec and William Fraser declare that they have no conflicts of interest.
Statement of human rights The study has been approved by the National
Research Ethics Committee North East, UK (REC reference 10/H0908/15) and
has been performed in accordance with the ethical standards laid down in the
1964 Declaration of Helsinki and its later amendments or comparable ethical
standards.
Electronic supplementary material
Online Resource 1
(DOCX 51 kb)
Online Resource 2
(DOCX 64 kb)
References
1.  van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001)
Epidemiology of fractures in England and Wales. Bone 29(6):517–522. doi:
10.1016/s8756-3282(01)00614-7
2.  Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999)
Mortality after all major types of osteoporotic fracture in men and women:
an observational study. Lancet 353(9156):878–882. doi: 10.1016/s0140-
6736(98)09075-8
3.  Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD (2011)
Mortality rates after incident non-traumatic fractures in older men and
women. Osteoporos Int 22(9):2439–2448. doi: 10.1007/s00198-010-1480-2
4.  Wehren LE, Hawkes WG, Orwig DL, Hebel JR, Zimmerman SI,
Magaziner J (2003) Gender differences in mortality after hip fracture: the
role of infection. J Bone Miner Res 18(12):2231–2237. doi:
10.1359/jbmr.2003.18.12.2231
5.  Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B (2010) Excess
mortality in men compared with women following a hip fracture. National
analysis of comedications, comorbidity and survival. Age Ageing 39(2):203–
209. doi: 10.1093/ageing/afp221
6.  Haentjens P, Johnell O, Kanis JA et al (2004) Evidence from data
searches and life-table analyses for gender-related differences in absolute
risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early
and sensitive marker of skeletal fragility in white men. J Bone Miner Res
19(12):1933–1944. doi: 10.1359/jbmr.040917
7.  Cuddihy MT, Gabriel SE, Crowson CS, O'Fallon WM, Melton LJ 3rd
(1999) Forearm fractures as predictors of subsequent osteoporotic fractures.
Osteoporos Int 9(6):469–475. doi: 10.1007/s001980050172
8.  Tuck SP, Raj N, Summers GD (2002) Is distal forearm fracture in men
due to osteoporosis? Osteoporos Int 13(8):630–636. doi:
10.1007/s001980200085
9.  Egund L, McGuigan F, Önnby K, Giwercman A, Akesson K (2016) High
prevalence of osteoporosis in men with distal radius fracture: a cross-
sectional study of 233 men. Calcif Tissue Int 99(3):250–258. doi:
10.1007/s00223-016-0142-6
10.  O'Neill TW, Cooper C, Finn JD et al (2001) Incidence of distal forearm
fracture in British men and women. Osteoporos Int 12(7):555–558. doi:
10.1007/s001980170076
11.  Lindau TR, Aspenberg P, Arner M, Redlundh-Johnell I, Hagberg L
(1999) Fractures of the distal forearm in young adults. An epidemiologic
description of 341 patients. Acta Orthop Scand 70(2):124–128. doi:
10.3109/17453679909011248
AQ6
12.  Kanis JA (2007) On behalf of the World Health Organization Scientific
Group. Assessment of osteoporosis at the primary health-care level.
Technical Report
13.  World Health Organisation Collaborating Centre for Metabolic Bone
Disease, University of Sheffield, UK. FRAX–WHO Fracture Risk
Assessment Tool. http://www.shef.ac.uk/FRAX/ . Accessed 24 Sept 2016
14.  Compston J, Cooper A, Cooper C et al (2009) Guidelines for the
diagnosis and management of osteoporosis in postmenopausal women and
men from the age of 50 years in the UK. Maturitas 62(2):105–108. doi:
10.1016/j.maturitas.2008.11.022
15.  Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism
in the elderly: consequences for bone loss and fractures and therapeutic
implications. Endocr Rev 22(4):477–501. doi: 10.1210/er.22.4.477
16.  National Institute for Health and Care Excellence (2014) Vitamin D:
increasing supplement use in at risk-groups.
https://www.nice.org.uk/guidance/ph56?unlid=7843398020162310553 .
Accessed 23 Sept 2016
17.  Fuerst T, Wu C, Genant HK et al (2009) Evaluation of vertebral fracture
assessment by dual X-ray absorptiometry in a multicenter setting.
Osteoporos Int 20(7):1199–1205. doi: 10.1007/s00198-008-0806-9
18.  Wu C, van Kuijk C, Li J et al (2000) Comparison of digitized images
with original radiography for semiquantitative assessment of osteoporotic
fractures. Osteoporos Int 11(1):25–30. doi: 10.1007/s001980050002
19.  Genant HK, Jergas M (2003) Assessment of prevalent and incident
vertebral fractures in osteoporosis research. Osteoporos Int 14(Suppl 3):S43–
S55. doi: 10.1007/s00198-002-1348-1
20.  Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive
summary of the 2013 International Society for Clinical Densitometry
Position Development Conference on bone densitometry. J Clin Densitom
16(4):455–466. doi: 10.1016/j.jocd.2013.08.004
21.  World Health Organisation (1994) Assessment of fracture risk and its
application to screening for postmenopausal osteoporosis. Report of a WHO
Study Group. WHO Technical Report Series, No.843
22.  Farr JN, Amin S, Melton LJ 3rd, Kirmani S et al (2014) Bone strength
and structural deficit in children and adolescents with a distal forearm
fracture resulting from mild trauma. J Bone Mineral Res 29(3):590–599. doi:
10.1002/jbmr.2071
23.  Oyen J, Rohde G, Hochberg M, Johnsen V, Haugeberg G (2011) Low
bone mineral density is a significant risk factor for low-energy distal radius
fractures in middle-aged and elderly men: a case control study. BMC
Musculoskelet Disord 12:67. doi: 10.1186/1471-2474-12-67
24.  Risto O, Hammar E, Hammar K et al (2012) Elderly men with a history
of distal radius fracture have significantly lower calcaneal bone density and
free androgen index than age-matched controls. Aging Male 15(1):59–62.
doi: 10.3109/13685538.2011.593659
25.  Nguyen TV, Centre JR, Sambrook PN, Eisman JA (2001) Risk factors
for proximal humerus, forearm, and wrist fractures in elderly men and
women: the Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol
153(6):587–595
26.  Kanterewicz E, Yanez A, Perez-Pons A, Codony I, Del Rio L, Diez-
Perez A (2002) Association between Colles' fracture and low bone mass:
age-based differences in postmenopausal women. Osteoporos Int
13(10):824–828. doi: 10.1007/s001980200114
27.  Scane AC, Francis RM, Sutcliffe AM, Francis MJ, Rawlings DJ,
Chapple CL (1999) Case-control study of the pathogenesis and sequelae of
symptomatic vertebral fractures in men. Osteoporos Int 9(1):91–97. doi:
10.1007/s001980050120
28.  Pande I, O'Neill TW, Pritchard C, Scott DL, Woolf AD (2000) Bone
mineral density, hip axis length and risk of hip fracture in men: results from
the Cornwall Hip Fracture Study. Osteoporos Int 11(10):866–870. doi:
10.1007/s001980070046
29.  Tuck SP, Scane AC, Fraser WD, Diver MJ, Eastell R, Francis RM
(2008) Sex steroids and bone turnover markers in men with symptomatic
vertebral fractures. Bone 43(6):999–1005. doi: 10.1016/j.bone.2008.08.123
30.  Borg J, Mollgaard A, Riis BJ (1995) Single X-ray absorptiometry:
performance characteristics and comparison with single photon
absorptiometry. Osteoporos Int 5(5):377–381. doi: 10.1007/bf01622260
31.  Taaffe DR, Lewis B, Marcus R (1994) Quantifying the effect of hand
preference on upper limb bone mineral and soft tissue composition in young
and elderly women by dual-energy X-ray absorptiometry. Clin Physiol
14(4):393–404. doi: 10.1111/j.1475-097x.1994.tb00398.x
32.  Walters J, Koo WW, Bush A, Hammami M (1998) Effect of hand
dominance on bone mass measurement in sedentary individuals. J Clin
Densitom 1(4):359–367. doi: 10.1385/jcd:1:4:359
33.  Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R (2008)
The relationship between serum TSH and bone mineral density in men and
postmenopausal women: the Tromso study. Thyroid 18(11):1147–1155. doi:
10.1089/thy.2008.0158
34.  Abe E, Marians RC, Yu W et al (2003) TSH is a negative regulator of
skeletal remodelling. Cell 115(2):151–156. doi: 10.1016/s0092-
8674(03)00771-2
35.  Ettinger B, Ensrud KE, Blackwell T et al (2013) Performance of FRAX
in a cohort of community-dwelling, ambulatory older men: the Osteoporotic
Fractures in Men (MrOS) study. Osteoporos Int 24(4):1185–1193. doi:
10.1007/s00198-012-2215-3
36.  Leslie WD, Berger C, Langsetmo L et al (2011) Construction and
validation of a simplified fracture risk assessment tool for Canadian women
and men: results from the CaMos and Manitoba cohorts. Osteoporos Int
22(6):1873–1883. doi: 10.1007/s00198-010-1445-5
37.  Leslie WD, Lix LM, Langsetmo L et al (2011) Construction of a
FRAX(R) model for the assessment of fracture probability in Canada and
implications for treatment. Osteoporos Int 22(3):817–827. doi:
10.1007/s00198-010-1464-2
38.  Schousboe JT, Vo T, Taylor BC et al (2016) Prediction of incident major
osteoporotic and hip fractures by trabecular bone score (TBS) and prevalent
radiographic vertebral fracture in older men. J Bone Miner Res 31(3):690–
697. doi: 10.1002/jbmr.2713
39.  Silman AJ (2003) Risk factors for Colles' fracture in men and women:
results from the European Prospective Osteoporosis Study. Osteoporos Int
14(3):213–218. doi: 10.1007/s00198-002-1364-1
